D-0383-2026 Class II Ongoing
FDA drug recall D-0383-2026 was initiated by The Harvard Drug Group LLC on Feb 17, 2026 and is designated Class II. Reason for recall: Defective container; inadequately sealed blister packaging. The recall status is ongoing. Affected quantity: 8892 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 11, 2026
- Initiation Date
- Feb 17, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8892 cartons
Product description
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Reason for recall
Defective container; inadequately sealed blister packaging.
Distribution pattern
Nationwide US.
Code information
Lot # N02640, Exp Date: 08/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0383-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026